Inogen, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Statements of Stockholders' Equity (Deficit)

Statements of Stockholders' Equity (Deficit) (USD $) In Thousands, except Share data	Total	Series A convertible preferred stock	Series G Preferred Stock	Common stock	Additional paid-in capital	Accumulated deficit	Accumulated deficit Series G Preferred Stock
Beginning Balance at Dec. 31, 2011	$ (75,566)us-gaap_StockholdersEquity	$ 247		$ 1		$ (75,814)
Beginning Balance, shares at Dec. 31, 2011		66,666		250,440
Stock-based compensation	60				60
Stock options exercised	3				3
Stock options exercised, shares				4,270
Warrants exercised	5				5
Warrants exercised, shares				17,386
Accretion of Series G financing costs	(55)						(55)
Deemed dividend on redeemable convertible preferred stock	(5,781)				(68)	(5,713)
Net income	564us-gaap_NetIncomeLoss					564
Ending Balance at Dec. 31, 2012	(80,770)us-gaap_StockholdersEquity	247		1		(81,018)
Ending Balance, shares at Dec. 31, 2012		66,666		272,096
Stock-based compensation	230				230
Stock options exercised	10				10
Stock options exercised, shares	8,874			8,878
Warrants exercised	1				1
Deemed dividend on redeemable convertible preferred stock	(7,278)				(241)	(7,037)
Net income	25,435us-gaap_NetIncomeLoss					25,435
Ending Balance at Dec. 31, 2013	(62,372)us-gaap_StockholdersEquity	247		1		(62,620)
Ending Balance, shares at Dec. 31, 2013		66,666		280,974
Stock-based compensation	1,451				1,363	88
Employee stock purchase	413				413
Employee stock purchase, shares				30,358
Stock options exercised	946			1	945
Stock options exercised, shares	736,519			736,519
Warrants exercised	61				61
Warrants exercised, shares				222,455
Reclassification of warrant liability	76				76
Deemed dividend on redeemable convertible preferred stock	(987)					(987)
Conversion of preferred stock	120,251	(247)	28,427	14	120,484
Conversion of preferred stock, shares		(66,666)	2,840,260	14,259,647
Issuance of common stock in connection with initial public offering	49,844			3	49,841
Issuance of common stock in connection with initial public offering, shares				3,529,411
Excess tax benefits from stock-based compensation arrangements	1,641				1,641
Net income	6,826us-gaap_NetIncomeLoss					6,826
Ending Balance at Dec. 31, 2014	$ 118,150us-gaap_StockholdersEquity			$ 19	$ 174,824	$ (56,693)
Ending Balance, shares at Dec. 31, 2014				19,059,364